129 related articles for article (PubMed ID: 16868451)
1. Hypokalemia in HIV patients on tenofovir.
Cirino CM; Kan VL
AIDS; 2006 Aug; 20(12):1671-3. PubMed ID: 16868451
[TBL] [Abstract][Full Text] [Related]
2. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
[TBL] [Abstract][Full Text] [Related]
3. Editorial comment: tenofovir-related nephrotoxicity--who's at risk?
Gupta Samir K
AIDS Read; 2007 Feb; 17(2):102-3. PubMed ID: 17323509
[No Abstract] [Full Text] [Related]
4. Causes and consequences of hypokalemia in patients on tenofovir disoproxil fumarate.
Shepp DH; Curtis S; Rooney JF
AIDS; 2007 Jul; 21(11):1479-81. PubMed ID: 17589195
[TBL] [Abstract][Full Text] [Related]
5. Effect of tenofovir on renal glomerular and tubular function.
Fux CA; Christen A; Zgraggen S; Mohaupt MG; Furrer H
AIDS; 2007 Jul; 21(11):1483-5. PubMed ID: 17589197
[TBL] [Abstract][Full Text] [Related]
6. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases.
Lockhart SM; Rathbun RC; Stephens JR; Baker DL; Drevets DA; Greenfield RA; Salvaggio MR; Vincent S
AIDS; 2007 Jun; 21(10):1370-3. PubMed ID: 17545718
[TBL] [Abstract][Full Text] [Related]
8. Prolonged exposure to tenofovir monotherapy 1 month after treatment discontinuation because of tenofovir-related renal failure.
Ter Heine R; Huitema AD; Jansen RS; Smits PH; van Gorp EC; Wagenaar JF; Beijnen JH; Mulder JW
Antivir Ther; 2009; 14(2):299-301. PubMed ID: 19430105
[TBL] [Abstract][Full Text] [Related]
9. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
Atta MG; Fine DM
AIDS Read; 2009 Mar; 19(3):118-9. PubMed ID: 19334329
[No Abstract] [Full Text] [Related]
10. Renal safety of tenofovir disoproxil fumarate.
Sax PE; Gallant JE; Klotman PE
AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
[TBL] [Abstract][Full Text] [Related]
11. The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients.
Kruse G; Esser S; Stocker H; Breske A; Koerber A; Kopperman M; Wiehler H; Ross B; Möcklinghoff C; Hill A; Becker M; Kurowski M
Antivir Ther; 2005; 10(2):349-55. PubMed ID: 15865230
[TBL] [Abstract][Full Text] [Related]
12. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
Gallant JE; Parish MA; Keruly JC; Moore RD
Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
[TBL] [Abstract][Full Text] [Related]
13. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir nephrotoxicity: focusing research questions and putting them into clinical context.
Szczech LA
J Infect Dis; 2008 Jan; 197(1):7-9. PubMed ID: 18171278
[No Abstract] [Full Text] [Related]
15. Editorial comment: tenofovir nephrotoxicity--vigilance required.
Fine DM
AIDS Read; 2005 Jul; 15(7):362-3. PubMed ID: 16044578
[No Abstract] [Full Text] [Related]
16. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
Crane HM; Kestenbaum B; Harrington RD; Kitahata MM
AIDS; 2007 Jul; 21(11):1431-9. PubMed ID: 17589189
[TBL] [Abstract][Full Text] [Related]
17. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
Psevdos G; Gonzalez E; Sharp V
AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
[TBL] [Abstract][Full Text] [Related]
18. Meeting notes from ICAAC. Tenofovir + ddI: a combination to avoid.
Sax PE
AIDS Clin Care; 2005 Jan; 17(1):6-7. PubMed ID: 15717372
[No Abstract] [Full Text] [Related]
19. Tenofovir and changes in renal function.
Gupta SK
Clin Infect Dis; 2005 Aug; 41(4):570-1; author reply 571. PubMed ID: 16028175
[No Abstract] [Full Text] [Related]
20. Improvement in chronic renal impairment following the discontinuation of tenofovir in two HIV-infected patients.
Gracey D; Post J; MacLeod C; McKenzie P
Nephrology (Carlton); 2011 May; 16(4):453-5. PubMed ID: 21518120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
